tiprankstipranks
Laboratorios Farmaceuticos Rovi, SA (ES:ROVI)
BME:ROVI
Spanish Market
ROVI
Laboratorios Farmaceuticos Rovi
RESEARCH TOOLSreports

Laboratorios Farmaceuticos Rovi (ROVI) Income Statement

39 Followers

Laboratorios Farmaceuticos Rovi Income Statement

Last quarter (Q4 2025), Laboratorios Farmaceuticos Rovi's total revenue was €218.42M, an increase of 9.68% from the same quarter last year. In Q4, Laboratorios Farmaceuticos Rovi's net income was €42.68M. See Laboratorios Farmaceuticos Rovi’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 743.48M€ 763.75M€ 829.51M€ 817.70M€ 648.68M
Gross Profit
€ 451.65M€ 478.35M€ 483.34M€ 519.61M€ 384.82M
Operating Expenses
€ 278.51M€ 298.80M€ 263.09M€ 263.76M€ 203.34M
Depreciation and Amortization
€ 30.37M€ 28.02M€ 24.33M€ 22.87M€ 21.36M
EBITDA
€ 203.52M€ 207.69M€ 245.81M€ 281.49M€ 204.72M
Operating Income
€ 173.14M€ 179.54M€ 220.25M€ 255.85M€ 181.57M
Other Income/Expenses
€ 10.12M€ -1.85M€ 154.00K€ 1.92M€ 1.24M
Pretax Income
€ 183.26M€ 177.69M€ 220.41M€ 257.97M€ 182.63M
Net Income
€ 140.44M€ 136.88M€ 170.34M€ 199.67M€ 153.08M
Per Share Metrics
Basic EPS
€ 2.75€ 2.67€ 3.29€ 3.73€ 2.76
Diluted EPS
€ 2.75€ 2.67€ 3.29€ 3.73€ 2.76
Weighted Average Shares Outstanding
 51.15M 51.27M 51.82M 53.47M 55.40M
Weighted Average Shares Outstanding (Diluted)
 51.15M 51.27M 51.82M 53.47M 55.40M
Currency in EUR

Laboratorios Farmaceuticos Rovi Earnings and Revenue History